Business

Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders

HALIFAX, Nova Scotia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced the results from its annual and special meeting of shareholders held earlier today (the “Meeting”). Based on the proxies received and the vote conducted at the Meeting, all tabled resolutions were approved by the shareholders of the Company (the “Sh

articleAppili Therapeutics Inc Class ASeptember 23, 20252/company/appili-therapeutics-inc/news/appili-therapeutics-announces-results-annual-210100623
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders

About this update from Appili Therapeutics Inc Class A

[{"type":"image","alt":"Appili Therapeutics Inc.","displaySize":"","headline":null,"caption":"Appili Therapeutics Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":174,"height":61,"url":"https://media.zenfs.com/en/globenewswire.com/0ffbb964adae4c4c44e58e70f361d392"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Gm4iD2zljen4lWwIosNX4Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTc0O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/0ffbb964adae4c4c44e58e70f361d392","width":174,"height":61}},"lazy":false},{"type":"text","content":"HALIFAX, Nova Scotia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced the results from its annual and special meeting of shareholders held earlier today (the “Meeting”).","length":350,"tagName":"p"},{"type":"text","content":"Based on the proxies received and the vote conducted at the Meeting, all tabled resolutions were approved by the shareholders of the Company (the “Shareholders”), including the election of the following directors for the ensuing year: Don Cilla, Brian Bloom, Theresa Matkovits, Juergen Froehlich, Armand Balboni and Prakash Gowd.","length":329,"tagName":"p"},{"type":"text","content":"Voting results for each director are summarized below:","length":54,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"max-width:33%;width:33%;min-width:33%;vertical-align:middle;text-align:left;padding-left:10.0px;border-top:solid black 1pt;border-right:solid black 1pt;border-bottom:solid black 1pt;border-left:solid black 1pt;text-align:center;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"Name of Nominee","length":15,"tagName":"p","attribs":{}}]},{"style":"max-width:34%;width:34%;min-width:34%;vertical-align:middle;text-align:left;padding-left:10.0px;border-top:solid black 1pt;border-right:solid black 1pt;border-bottom:solid black 1pt;border-left:solid black 1pt;text-align:center;vertical-align:middle;vertical-align:middle;","val":[{"type":"text","content":"Votes For","length":9,"tagName":"p","attribs":{}}]},{"style":"max-width:33%;width:33%;min-width:33%;vertical-align:middle;text-align:left;padding-left:10.0px;border-top:solid black 1pt;border-right:solid black 1pt;b...

More updates from Appili Therapeutics Inc Class A

Brian Bloombiopharmaceutical companythe CompanyVoting resultsJuergen FroehlichDon CillaCompanyArmand BalboniPrakash Gowd